KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Nektar Therapeutics (NKTR) Asset Utilization Ratio (2016 - 2025)

Nektar Therapeutics has reported Asset Utilization Ratio over the past 15 years, most recently at 0.19 for Q4 2025.

  • Quarterly results put Asset Utilization Ratio at 0.19 for Q4 2025, down 40.99% from a year ago — trailing twelve months through Dec 2025 was 0.19 (down 40.99% YoY), and the annual figure for FY2025 was 0.19, down 32.59%.
  • Asset Utilization Ratio for Q4 2025 was 0.19 at Nektar Therapeutics, down from 0.25 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for NKTR hit a ceiling of 0.32 in Q2 2025 and a floor of 0.07 in Q2 2021.
  • Median Asset Utilization Ratio over the past 5 years was 0.18 (2023), compared with a mean of 0.18.
  • Biggest five-year swings in Asset Utilization Ratio: soared 73.79% in 2023 and later plummeted 40.99% in 2025.
  • Nektar Therapeutics' Asset Utilization Ratio stood at 0.09 in 2021, then skyrocketed by 45.01% to 0.12 in 2022, then soared by 73.79% to 0.21 in 2023, then surged by 50.0% to 0.32 in 2024, then plummeted by 40.99% to 0.19 in 2025.
  • The last three reported values for Asset Utilization Ratio were 0.19 (Q4 2025), 0.25 (Q3 2025), and 0.32 (Q2 2025) per Business Quant data.